JPH0370971B2 - - Google Patents
Info
- Publication number
- JPH0370971B2 JPH0370971B2 JP62245805A JP24580587A JPH0370971B2 JP H0370971 B2 JPH0370971 B2 JP H0370971B2 JP 62245805 A JP62245805 A JP 62245805A JP 24580587 A JP24580587 A JP 24580587A JP H0370971 B2 JPH0370971 B2 JP H0370971B2
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic surgery
- aid
- ultraviolet rays
- lens
- shaped body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Eye Examination Apparatus (AREA)
Description
本発明は、眼科手術用補助具に関するものであ
る。
The present invention relates to an ophthalmic surgery aid.
太陽光線に含まれる紫外線のうち約280nm以下
の紫外線はほとんど大気圏上層のオゾン層によつ
て吸収され、それ以上の波長の光が地表上に降り
注いでいる。
そして、これらの光のうち、水晶体を持つ眼に
おいては、約280〜320nmの波長の紫外線は角膜
で吸収され、約320〜400nmの波長の近紫外線は
水晶体で吸収され、約400〜780nmの波長の可視
光線及び約780〜1400nmの波長の近赤外線が網膜
に達する。尚、約1400nm以上の波長の赤外線は
角膜によつて吸収されている。
従つて、眼のある種の障害あるいは疾病、例え
ば白内障等の為に外科的手術によつて水晶体を摘
出した場合、水晶体によつて吸収されていた約
320〜400nmの波長の近紫外線が網膜にまで達し
てしまい、その結果網膜に障害が起きることにな
る。
この為、水晶体摘出手術を受け、無水晶体用の
眼内レンズを装着する場合にあつては、この眼内
レンズ自体によつて約320〜400nmの波長の近紫
外線が吸収カツトされるような構成としておくこ
とが望まれており、このような観点から眼内レン
ズは約320〜400nmの波長の近紫外線等を吸収す
る紫外線吸収剤を添加したポリマーで構成するこ
とが提案されている。
ところが、このような紫外線吸収剤を添加した
材料で構成した眼内レンズが用いられても、網膜
障害の発生することが指摘されるに至つている。
そして、このような網膜障害の発生に対する研
究が鋭意押し進められていくうちに、これは眼内
レンズ移植時における手術顕微鏡光によるもので
はないかと考えられるに至つた。
すなわち、眼科手術手技上、同軸照明光により
後嚢を確認する必要があり、顕微鏡光軸が術眼光
軸に近く、又、眼内レンズの集光によりエネルギ
ー密度の高い光が球後麻酔や索引糸で固定された
術眼後極部に持続的に集束することによるのでは
ないかと考えられるに至つた。
実際、サル眼や人眼における実験において、顕
微鏡光を7.5〜60分間照射すると、網膜障害の発
生することが確認されている。
又、手術用顕微鏡光の光線は強いものであるこ
とから、網膜ばかりでなく、前眼部の角膜への障
害も必配されるに至つている。
このような観点から、手術に際して遮光性のレ
ンズ形状物を角膜上に載置することが提案されて
いる。
Of the ultraviolet rays contained in sunlight, most of the ultraviolet rays with a wavelength of about 280 nm or less are absorbed by the ozone layer in the upper atmosphere, and light with longer wavelengths falls on the earth's surface. Of these lights, in eyes with crystalline lenses, ultraviolet rays with wavelengths of approximately 280 to 320 nm are absorbed by the cornea, near ultraviolet rays with wavelengths of approximately 320 to 400 nm are absorbed by the crystalline lens, and ultraviolet rays with wavelengths of approximately 400 to 780 nm are absorbed by the cornea. visible light and near-infrared light with wavelengths of approximately 780 to 1400 nm reach the retina. Note that infrared rays with wavelengths of about 1400 nm or more are absorbed by the cornea. Therefore, when the crystalline lens is surgically removed due to certain eye disorders or diseases, such as cataracts, approximately
Near ultraviolet rays with a wavelength of 320 to 400 nm can reach the retina, resulting in damage to the retina. For this reason, when undergoing lens removal surgery and wearing an intraocular lens for aphakia, the intraocular lens itself must be constructed so that it absorbs and cuts near ultraviolet rays with a wavelength of about 320 to 400 nm. From this point of view, it has been proposed that intraocular lenses be made of a polymer containing an ultraviolet absorber that absorbs near ultraviolet rays having a wavelength of about 320 to 400 nm. However, it has been pointed out that even when intraocular lenses made of materials containing such ultraviolet absorbers are used, retinal disorders occur. As research into the occurrence of such retinal disorders progressed, it became possible to believe that this was caused by the light from the surgical microscope at the time of intraocular lens implantation. In other words, due to ophthalmic surgical techniques, it is necessary to confirm the posterior capsule using coaxial illumination light, the optical axis of the microscope is close to the optical axis of the surgical eye, and the light with high energy density is used for retrobulbar anesthesia and index imaging due to the condensation of the intraocular lens. We have come to believe that this is due to continuous focusing at the posterior pole of the surgical eye, which is fixed with a thread. In fact, in experiments on monkey eyes and human eyes, it has been confirmed that retinal damage occurs when exposed to microscopic light for 7.5 to 60 minutes. In addition, since the light rays from a surgical microscope are strong, they inevitably cause damage not only to the retina but also to the cornea of the anterior segment of the eye. From this point of view, it has been proposed to place a light-blocking lens-shaped object on the cornea during surgery.
本発明者は、前記した遮光性のレンズ形状物で
は手術時に前房透見が不能であり、特に眼内レン
ズ挿入後の強角膜縫合時において縫合の強さを角
膜にしわがよることより判断しているが、この判
断が極めてしにくく、この遮光性のレンズ形状物
では充分なものでなく、そこでさらに研究開発を
鋭意押し進めていくうちに、遮光性にしたもので
なくとも良いことを見出すに至つた。
すなわち、本発明者は、網膜障害発生の主な原
因は顕微鏡光における波長約320〜400nmの近紫
外線であることを究明すると共に、眼内レンズ挿
入後の眼内レンズによる集光の為に網膜障害が起
き得ること、又、術中水晶体摘出までの有水晶体
眼では水晶体が近紫外線フイルターとして働き、
網膜障害が起きないと思われていたものの、眼球
固定されている眼科手術では有水晶体眼でも時間
が長くかかれば少なからず影響があるのではない
かと考えられるに至つたこと、さらには水晶体摘
出から眼内レンズ挿入時まで一定時間近紫外線フ
イルターが欠損した無水晶体眼となることから、
眼内レンズ挿入までの手術操作が長くなると網膜
障害が起きる可能性のあることを究明し、手術開
始より手術終了までの手術全般にわたつて約320
〜400nmの近紫外線をカツトしておけば網膜障害
が起きなくなるとの知見を得るに至つたのであ
る。
従つて、眼内レンズ移植手術に際して角膜上に
載置されるレンズ形状物を、遮光性のものとして
なくても、近紫外線をカツトする材料で構成して
おけば、網膜障害が起きにくいことを見出したの
である。
そして、このレンズ形状物を透光性の材料で構
成していても網膜障害が起きないのみでなく、手
術に際して前房透見が可能であり、そして眼内レ
ンズ挿入後の強角膜縫合時に、このレンズ形状物
を角膜上から除去しなくても、縫合の強さを角膜
に生じるしわの程度により判断できるメリツトを
有していたのである。
又、この手術眼の角膜上に載置することになる
眼科手術用補助具は、手術後にあつては除去しな
ければならず、又、手術中においても時には移動
させなければならないこともあり、従つてこの眼
科手術用補助具の前面(角膜面と反対側)部にお
ける中心からずれた位置に突部を設けておくと、
前記の作業を極めて容易に行なえるようになる。
尚、この眼科手術用補助具の形状は、例えば直
径が約6〜12mm、好ましくは約9〜10mm程度のも
のでよく、そして内面(角膜面)側のカーブの曲
率は約7.2〜8.6mm、好ましくは約8.2〜8.3mmであ
つて、そして中心厚が約0.1〜1.0mm、好ましくは
約0.2〜0.5mmであり、前面側のカーブは内面側の
カーブとほとんど同じパラレルのものであるか、
あるいは0〜−0.3Dのマイナスパワーを有する
凹レンズタイプのものであることが望ましい。す
なわち、角膜上に載せて使用するものであるか
ら、この眼科手術用補助具はコンタクトレンズの
ような形に似せて構成させておけば良い(但し、
コンタクトレンズのように平面図が円形でなくて
も良い)ものの、顕微鏡光を集束させないように
する為、この眼科手術用補助具はパワーが零か又
はマイナスのものとなるような形にしておくこと
が望ましい。
又、この眼科手術用補助具は、上述した通り、
近紫外線をカツトする透見性材料で構成しておか
ねばならないが、出来得ればさらには軟性な特性
をも有している方が望ましい。すなわち、いわゆ
るハードコンタクトレンズのような例えばポリメ
チルメタクリレートのような材料で構成している
と、このような硬質系材料で構成した眼科手術用
補助具を除去する時、角膜(眼球)を大きく変形
させる可能性があつたからによる。
又、2−ヒドロキシエチルアクリレートのよう
ないわゆる含水性のソフトコンタクトレンズ材料
で構成した眼科手術用補助具の場合には、使用に
際して顕微鏡光が照射されていること等によつて
角膜上に載置している眼科手術用補助具が乾燥す
る傾向にあり、これによつて眼科手術用補助具が
変形し、角膜上から脱落することもあつたので、
このような欠点がない材料、すなわち非含水性の
タイプの材料で構成しておくことが望ましかつ
た。
そして、上記のような特性を備えた材料とし
て、例えばジメチルシリコーンあるいはメチルフ
エニルシリコーンのようなシリコーンゴムがある
が、このシリコーンゴムは疎水性を示すことか
ら、その表面が親水性となるよう親水性化処理を
しておくことが望ましかつた。
尚、このような親水性化処理は、例えばシリコ
ーンゴムを用いて所望の形に構成した眼科手術用
補助具を、酸素、窒素、あるいは不活性ガス雰囲
気中で、低温プラズマ処理したり、あるいはN−
ビニルピロリドン、2−ヒドロキシエチルアクリ
レート、エチレングリコール等の水溶性高分子単
量体の雰囲気中で低温プラズマ重合を行なわせる
ことが挙げられる。
そして、このような眼科手術用補助具は。例え
ばジメチルシロキサンあるいはメチルフエニルシ
ロキサンのようなシリコーンゴムと、紫外線及び
近紫外線吸収材料として、例えば緑色201号、202
号、402号のような緑色色素、黄色204号、205号、
405号のような黄色色素、赤色202号、204号、206
号のような赤色色素、青色204号、403号、404号
のような青色色素、紫色201号、401号のような紫
色色素、褐色201号のような褐色色素、橙色203
号、204号、401号のような橙色色素といつた所定
の法定色素を適宜選択し、これらを所定量充分に
混合分散させ、その後充分に脱泡した後、これを
所定形状の鋳型内に注入し、その後加熱硬化させ
るか、又は上記のようなシリコーンゴムを所定形
状の鋳型内に注入して加熱硬化させ、その後これ
を取り出して上記のような法定色素を溶かした溶
液中に浸漬し、法定色素を内部に介在させること
によつて得られる。
The inventor of the present invention found that the above-mentioned light-shielding lens shape does not allow visualization of the anterior chamber during surgery, and that the strength of the suture can be determined based on the creases in the cornea, especially when suturing the sclerocornea after inserting an intraocular lens. However, this judgment was extremely difficult to make, and this light-shielding lens shape was not sufficient, so as we continued our research and development, we discovered that it did not need to be light-shielding. I've reached it. That is, the present inventor has determined that the main cause of retinal damage is near ultraviolet rays with a wavelength of about 320 to 400 nm in microscopic light, and the retina In addition, in phakic eyes until lens removal during surgery, the crystalline lens acts as a near-ultraviolet filter,
Although it was thought that retinal damage would not occur, it has come to be thought that even phakic eyes may be affected to some extent if it takes a long time during eye surgery in which the eyeball is fixed, and furthermore, it has become clear that retinal damage may occur even in phakic eyes. Because the near-UV filter is missing for a certain period of time until the intraocular lens is inserted, the eye becomes aphakic.
It was discovered that retinal damage may occur if the surgical procedure leading up to the insertion of an intraocular lens is prolonged, and approximately 320 patients were diagnosed during the entire procedure from the start of the surgery to the end of the surgery.
They came to the knowledge that if near-ultraviolet rays of ~400 nm are blocked, retinal damage will not occur. Therefore, even if the lens-shaped object placed on the cornea during intraocular lens implantation surgery is made of a material that blocks near-ultraviolet rays, it is possible to reduce the likelihood of retinal damage. I found it. Even if this lens shape is made of a translucent material, it not only does not cause retinal damage, but also enables visualization of the anterior chamber during surgery. This method had the advantage that the strength of the suture could be judged by the degree of wrinkles produced on the cornea without having to remove the lens-shaped object from above the cornea. In addition, the ophthalmic surgery aids that will be placed on the cornea of the operated eye must be removed after the surgery, and may also need to be moved during the surgery. Therefore, if a protrusion is provided at a position offset from the center of the front surface (opposite the corneal surface) of this ophthalmic surgery aid,
The above operations can be performed extremely easily. The shape of this ophthalmic surgery aid may be, for example, about 6 to 12 mm in diameter, preferably about 9 to 10 mm, and the curvature of the inner surface (corneal surface) side is about 7.2 to 8.6 mm. preferably about 8.2 to 8.3 mm, and the center thickness is about 0.1 to 1.0 mm, preferably about 0.2 to 0.5 mm, and the front curve is almost parallel to the inner curve;
Alternatively, it is preferable to use a concave lens type having a negative power of 0 to -0.3D. In other words, since it is used by placing it on the cornea, this ophthalmic surgery aid may be configured to resemble a contact lens (however,
Although the top view does not have to be circular like a contact lens), in order to avoid converging the microscope light, this ophthalmic surgery aid should be shaped so that the power is zero or negative. This is desirable. In addition, as mentioned above, this ophthalmic surgery aid has the following features:
It must be made of a see-through material that blocks near-ultraviolet rays, but if possible, it is also desirable to have soft properties. In other words, if a so-called hard contact lens is made of a material such as polymethyl methacrylate, the cornea (eyeball) may be significantly deformed when the ophthalmic surgical aid made of such a hard material is removed. Because there was a possibility that it would happen. In addition, in the case of ophthalmic surgical aids made of a so-called water-containing soft contact lens material such as 2-hydroxyethyl acrylate, it is difficult to place them on the cornea by being irradiated with microscopic light during use. The ophthalmic surgery aids that were used tended to dry out, which caused them to become deformed and sometimes fall off the cornea.
It would be desirable to use a material that does not have such drawbacks, that is, a non-water-containing material. Silicone rubbers such as dimethyl silicone or methylphenyl silicone are examples of materials with the above-mentioned properties, but since these silicone rubbers are hydrophobic, they are treated with hydrophilic materials to make the surface hydrophilic. It would have been desirable to undergo sexualization treatment. In addition, such hydrophilic treatment can be carried out, for example, by subjecting an ophthalmic surgical aid made of silicone rubber to a desired shape to low-temperature plasma treatment in an oxygen, nitrogen, or inert gas atmosphere, or by treating it with N −
Examples include performing low-temperature plasma polymerization in an atmosphere of a water-soluble polymer monomer such as vinylpyrrolidone, 2-hydroxyethyl acrylate, or ethylene glycol. And such ophthalmic surgery aids. Silicone rubbers, such as dimethylsiloxane or methylphenylsiloxane, and as ultraviolet and near-UV absorbing materials, e.g. Green No. 201, 202
No., green pigment like No. 402, yellow No. 204, No. 205,
Yellow dye like No. 405, red No. 202, 204, 206
Red pigments such as No. 204, Blue pigments such as No. 403, Blue pigments such as No. 404, Purple pigments such as No. 401, Purple pigments such as No. 401, Brown pigments such as Brown No. 201, Orange pigments such as No. 203
Appropriately select prescribed legal pigments such as orange pigments such as No. 1, No. 204, and No. 401, sufficiently mix and disperse a predetermined amount of these, and after thoroughly degassing, pour this into a mold of a predetermined shape. Either the silicone rubber as described above is injected into a mold of a predetermined shape and cured by heating, and then the silicone rubber is taken out and immersed in a solution in which a legal dye as described above is dissolved. Obtained by interposing a legal dye inside.
第1図は本発明に係る眼科手術用補助具の1実
施例の斜視図、第2図はこの眼科手術用補助具の
使用を示す説明図である。
ジメチルシロキサンと、法定色素の赤色501号、
黄色204号、緑色204号及び橙色203号とを所定量
混合分散させ、そして充分に脱泡させた後、これ
を所定形状の鋳型内に注入し、所定温度に加熱し
て硬化させ、硬化後鋳型よりこれを取り出し、第
1図に示される如くの眼科手術用補助具1を得
る。
尚、この眼科手術用補助具1の内面2側のカー
ブの曲率は8.25mm、中心部の厚みは0.4mm、直径
9mmで、パワーが−1.0Dのものとなる凹レンズ
形状に成型されたものであり、さらに中心からず
れた周辺部の前面3側の位置に直径2mm、長さ3
mmの軸4が設けられた構成となつている。
このように第1図に示す如くの形に成型された
眼科手術用補助具を120℃で20分間のオートクレ
ーブ処理を2回行なつて充分に硬化させると共に
余除色素の放出処理を行ない、最後に空気雰囲気
下での低温プラズマ処理を行ない、眼科手術用補
助具1表面の親水性化処理を行なう。
このようにして得られた眼科手術用補助具1の
光線透過率を島津製作所製のUV−265FW分光光
度計を用いて測定すると、第3図に示す如く、
200〜400nmの波長領域では透過率が30%以下、
400〜500nmの波長領域では透過率が約40〜60%、
500〜800nmの波長領域では透過率が約75%以上
であり、この眼科手術用補助具1は充分に紫外
線、近紫外線及び一部可視光線をカツトするもの
であり、かつ透見性のものであつた。
又、この眼科手術用補助具1について、有害物
の析出の有無である安全性試験(厚生省告示第
302号)を行なつたが、炭酸ナトリウム、クエン
酸及び水各々の溶出試験に全て合格していた。
又、滅菌精製水中で約30分間煮沸消毒を行なつ
ても何等の変化も認められなかつたので、この眼
科手術用補助具1は極めて簡単な手段によつて滅
菌処理できるものである。
そして、上記のような眼科手術用補助具1を第
2図に示す如く、手術眼の角膜11上に載置し、
そしてツアイス6C型顕微鏡を用い、光源12と
して常使用の照度領域下で眼内レンズの移植手術
を行なつた所、この手術に際して前房透見が可能
であり、前房変化が容易に確認できるものであ
り、又、角膜上で安定しており、手術操作を妨げ
るものでなく、さらには角膜障害及び網膜障害の
発生も認められなかつた。
実施例 2
所定量のジメチルフエニルシロキサンを所定形
状の鋳型内に注入して加熱硬化処理し、その後こ
れを取り出し、第1図に示す形状の未染色の眼科
手術用補助具を得る。
その後、これを法定色素の赤色501号、黄色204
号及び緑色202号を溶かしたエタノール溶液中に
約40分間浸漬して染色処理する。
そして、この後、表面についている色素を洗浄
除去した後、121℃で20分間のオートクレーブ処
理を2回行ない、最後に空気雰囲気下での低温プ
ラズマ処理を行ない、眼科手術用補助具を得る。
尚、この眼科手術用補助具の内面側のカーブの
曲率は8.30mm、中心部の厚みは0.4mm、直径9mm
で、パワーが−0.5Dのものとなる凹レンズ形状
のものであり、そして中心からずれた周辺部の前
面側の位置に直径2m、長さ3mmの軸が設けられ
た構成となつている。
そして、この眼科手術用補助具の光線透過率を
UV−265FW分光光度計で測定すると、200〜
400nmの波長領域では透過率が10%以下、400〜
500nmの波長領域では透過率が15〜25%、500〜
800nmの波長領域では透過率が60〜70%であり、
この眼科手術用補助具は充分に紫外線、近紫外線
及び一部可視光線をカツトするものであり、か
つ、透見性のものであつた。
又、厚生省告示第302号の安定性試験にも合格
しており、かつ、煮沸消毒処理も可能であり、さ
らには手術に際して角膜障害及び網膜障害が起き
ず、しかも手術の作業性も良いものであつた。
FIG. 1 is a perspective view of one embodiment of the ophthalmic surgery aid according to the present invention, and FIG. 2 is an explanatory view showing the use of this ophthalmic surgery aid. Dimethylsiloxane and legal dye Red No. 501,
After mixing and dispersing a predetermined amount of Yellow No. 204, Green No. 204, and Orange No. 203 and sufficiently degassing, this is poured into a mold of a predetermined shape, heated to a predetermined temperature and cured, and after curing. This is removed from the mold to obtain an ophthalmic surgery aid 1 as shown in FIG. The curvature of the curve on the inner surface 2 side of this eye surgery aid 1 is 8.25 mm, the thickness at the center is 0.4 mm, the diameter is 9 mm, and it is molded into a concave lens shape with a power of -1.0D. 2mm in diameter and 3 in length on the front 3 side of the periphery, which is further shifted from the center.
It has a configuration in which a shaft 4 of mm is provided. The ophthalmic surgery aid molded into the shape shown in Figure 1 was autoclaved twice at 120°C for 20 minutes to fully harden it and release the residual dye. A low-temperature plasma treatment is performed in an air atmosphere to make the surface of the ophthalmic surgery aid 1 hydrophilic. When the light transmittance of the ophthalmic surgery aid 1 thus obtained was measured using a UV-265FW spectrophotometer manufactured by Shimadzu Corporation, as shown in FIG.
In the wavelength range of 200 to 400 nm, the transmittance is less than 30%,
In the wavelength range of 400 to 500 nm, the transmittance is approximately 40 to 60%,
The transmittance is about 75% or more in the wavelength range of 500 to 800 nm, and this eye surgery aid 1 sufficiently blocks ultraviolet rays, near ultraviolet rays, and some visible light, and is transparent. It was hot. In addition, regarding this ophthalmic surgery aid 1, a safety test (Ministry of Health and Welfare Notification No.
No. 302) was carried out, and all of the dissolution tests for sodium carbonate, citric acid, and water were passed. In addition, no change was observed even after boiling in sterile purified water for about 30 minutes, so this ophthalmic surgery aid 1 can be sterilized by extremely simple means. Then, as shown in FIG. 2, the ophthalmic surgery aid 1 as described above is placed on the cornea 11 of the operated eye,
Then, the intraocular lens implantation surgery was performed using a Zeiss 6C type microscope under the normally used illumination range as the light source 12. During this surgery, it was possible to see through the anterior chamber, and changes in the anterior chamber could be easily confirmed. Moreover, it was stable on the cornea and did not interfere with surgical operations, and furthermore, no corneal or retinal disorders were observed. Example 2 A predetermined amount of dimethylphenylsiloxane is injected into a mold of a predetermined shape, heated and hardened, and then taken out to obtain an undyed ophthalmic surgical aid having the shape shown in FIG. After that, this is legally dyed red No. 501 and yellow No. 204.
No. 202 and Green No. 202 are immersed in an ethanol solution for about 40 minutes for dyeing. Then, after washing and removing the dye attached to the surface, autoclave treatment is performed twice for 20 minutes at 121° C., and finally low-temperature plasma treatment is performed in an air atmosphere to obtain an ophthalmic surgery aid. The curvature of the inner surface of this eye surgery aid is 8.30 mm, the thickness of the center is 0.4 mm, and the diameter is 9 mm.
It has a concave lens shape with a power of -0.5D, and a shaft with a diameter of 2 m and a length of 3 mm is provided at a position on the front side of the peripheral part offset from the center. Then, we determined the light transmittance of this ophthalmic surgery aid.
When measured with a UV-265FW spectrophotometer, it is 200~
Transmittance is less than 10% in the 400nm wavelength region, 400~
In the wavelength range of 500nm, the transmittance is 15~25%, 500~
In the wavelength range of 800nm, the transmittance is 60-70%,
This aid for ophthalmologic surgery sufficiently blocks ultraviolet rays, near ultraviolet rays, and some visible rays, and is transparent. In addition, it has passed the stability test of the Ministry of Health and Welfare Notification No. 302, and can be sterilized by boiling.Furthermore, it does not cause corneal or retinal damage during surgery, and has good operability during surgery. It was hot.
本発明に係る眼科手術用補助具は、近紫外線を
カツトする透見性材料を用いて角膜上に装着でき
る略レンズ形状に構成され、さらにこの略レンズ
形状体の中心からずれた位置の前面部に突部が構
成されたので、この眼科手術用補助具を角膜上に
装着して眼科手術を行なえば、顕微鏡光による網
膜障害及び角膜障害の発生を大幅になくすことが
できるようになり、又、強角膜縫合時において縫
合の強さを角膜に生じるしわの程度で知ることが
できるから縫合作業を極めて正確に行なえるもの
であり、又、手術中に光が照射されていても角膜
の乾燥防止にも効果があり、さらには手術後にこ
の眼科手術用補助具を角膜上から取り除くに際し
て角膜を傷付けることなく、かつ、極めて容易に
行なえる等の特長を有する。
The ophthalmic surgery aid according to the present invention is formed into a substantially lens shape that can be worn on the cornea using a see-through material that blocks near-ultraviolet rays, and further includes a front surface located at a position offset from the center of the substantially lens-shaped body. Since the projecting part is configured on the ophthalmic surgery, if this ophthalmic surgical aid is attached to the cornea and ophthalmic surgery is performed, it is possible to significantly eliminate the occurrence of retinal damage and corneal damage caused by microscopic light. When suturing the sclerocornea, the strength of the suture can be determined by the degree of wrinkles that occur on the cornea, so the suturing work can be performed extremely accurately, and it also prevents the cornea from drying out even when exposed to light during surgery. It is also effective in prevention, and furthermore, the ophthalmic surgery aid can be removed from the cornea after surgery without damaging the cornea and can be done extremely easily.
第1図は本発明に係る眼科手術用補助具の1実
施例の斜視図、第2図はこの眼科手術用補助具を
使用しての手術時の説明図、第3図は光線透過率
を示すグラフである。
1……眼科手術用補助具、2……内面、3……
前面、4……軸(突部)、11……角膜、12…
…光源。
Fig. 1 is a perspective view of one embodiment of the ophthalmic surgery aid according to the present invention, Fig. 2 is an explanatory diagram of an operation performed using this ophthalmic surgery aid, and Fig. 3 shows the light transmittance. This is a graph showing. 1...Auxiliary tool for ophthalmic surgery, 2...Inner surface, 3...
Front surface, 4... axis (projection), 11... cornea, 12...
…light source.
Claims (1)
膜上に装着できる略レンズ形状に構成され、さら
にこの略レンズ形状体の中心からずれた位置の前
面部に突部が構成されたことを特徴とする眼科手
術用補助具。 2 特許請求の範囲第1項記載の眼科手術用補助
具において、略レンズ形状体がパラレルカーブな
いしはマイナスパワーを有する形状であるもの。 3 特許請求の範囲第1項記載の眼科手術用補助
具において、近紫外線のカツト範囲は少なくとも
約320〜400nmのものであり、このカツト範囲に
おいてカツト率が約30%以上であるもの。 4 特許請求の範囲第1項記載の眼科手術用補助
具において、略レンズ形状体は紫外線及び近紫外
線をカツトする軟性かつ透見性材料で構成された
もの。 5 特許請求の範囲第1項記載の眼科手術用補助
具において、略レンズ形状体は紫外線及び近紫外
線をカツトする軟性で、実質上非含水性かつ透見
性材料で構成されたもの。 6 特許請求の範囲第1項、第4項又は第5項記
載の眼科手術用補助具において、略レンズ形状体
は紫外線及び近紫外線吸収剤を添加したシリコー
ンゴム材料で構成されたもの。 7 特許請求の範囲第6項記載の眼科手術用補助
具において、シリコーンゴムはジメチルシリコー
ンを主成分としたもの。 8 特許請求の範囲第6項記載の眼科手術用補助
具において、シリコーンゴムはメチルフエニルシ
リコーンを主成分としたもの。 9 特許請求の範囲第6項、第7項又は第8項記
載の眼科手術用補助具において、シリコーンゴム
製の略レンズ形状体の表面は親水性処理が行なわ
れたもの。[Scope of Claims] 1. It is constructed in a substantially lens shape that can be worn on the cornea using a see-through material that blocks near ultraviolet rays, and furthermore, a protrusion is provided on the front surface of the substantially lens-shaped body at a position offset from the center. An ophthalmic surgery aid characterized by the following configurations: 2. The aid for ophthalmic surgery according to claim 1, in which the substantially lens-shaped body has a parallel curve or a shape having negative power. 3. The aid for ophthalmic surgery according to claim 1, which has a cutting range of near ultraviolet rays of at least about 320 to 400 nm, and has a cutting rate of about 30% or more in this cutting range. 4. In the ophthalmic surgery aid according to claim 1, the substantially lens-shaped body is made of a soft and see-through material that blocks ultraviolet rays and near ultraviolet rays. 5. In the ophthalmic surgery aid as set forth in claim 1, the substantially lens-shaped body is made of a soft, substantially water-free and see-through material that blocks ultraviolet rays and near ultraviolet rays. 6. In the ophthalmic surgery aid according to claim 1, 4, or 5, the substantially lens-shaped body is made of a silicone rubber material to which an ultraviolet and near ultraviolet absorber is added. 7. In the ophthalmic surgery aid as set forth in claim 6, the silicone rubber is mainly composed of dimethyl silicone. 8. In the ophthalmic surgery aid as set forth in claim 6, the silicone rubber is mainly composed of methylphenyl silicone. 9. An ophthalmic surgery aid according to claim 6, 7, or 8, wherein the surface of the silicone rubber substantially lens-shaped body is subjected to hydrophilic treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62245805A JPH0191860A (en) | 1987-10-01 | 1987-10-01 | Supporting instrument for ophthalmologic operation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62245805A JPH0191860A (en) | 1987-10-01 | 1987-10-01 | Supporting instrument for ophthalmologic operation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0191860A JPH0191860A (en) | 1989-04-11 |
| JPH0370971B2 true JPH0370971B2 (en) | 1991-11-11 |
Family
ID=17139105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62245805A Granted JPH0191860A (en) | 1987-10-01 | 1987-10-01 | Supporting instrument for ophthalmologic operation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0191860A (en) |
-
1987
- 1987-10-01 JP JP62245805A patent/JPH0191860A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0191860A (en) | 1989-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11833081B2 (en) | Vision correction with laser refractive index changes | |
| ES2585632T3 (en) | Ophthalmic reflective-diffractive device and compositions useful for manufacturing it | |
| US4556998A (en) | Artificial intraocular lenses and method for their surgical implantation | |
| EP2983618B1 (en) | Phakic lens device with openings and concentric annular zones | |
| US4734095A (en) | Self-centering artificial introaocular lens | |
| US20150359625A1 (en) | Toric-diffractive lens | |
| JPS6364981B2 (en) | ||
| EA011798B1 (en) | Therapeutic contact lens for pseudoaphakic eyes and/or eyes undergoing a neurodegenerative process | |
| ES3002757T3 (en) | Intraocular lens customized for astigmatism or combined astigmatism and presbyopia | |
| Newland et al. | Neodymium: YAG laser damage on silicone intraocular lenses: a comparison of lesions on explanted lenses and experimentally produced lesions | |
| JP4906257B2 (en) | Method for producing surface-treated intraocular lens and intraocular lens for inhibiting secondary cataract | |
| GB2180160A (en) | Self-centering artificial intraocular lens | |
| Alejandre-Alba et al. | Intraocular photobonding to enable accommodating intraocular lens function | |
| JPH0370971B2 (en) | ||
| Marcos et al. | Toward new engagement paradigms for intraocular lenses: light-initiated bonding of capsular bag to lens materials | |
| Corboy et al. | Neodymium: YAG laser capsulotomy with a biconvex intraocular lens | |
| GB2163653A (en) | Dry artificial intraocular lenses and method for their surgical implantation | |
| Myers et al. | Intraocular lens design for the neodymium: YAG laser | |
| Alejandre et al. | Intraocular photobonding to enable accommodating intraocular lens function | |
| JPWO1989007952A1 (en) | Manufacturing method for intraocular lens for correcting cyanopsia | |
| Lubeck | February consultation# 9 | |
| FR2569557A1 (en) | Improved artificial intraocular lenses | |
| Schlichtemeier | Collagen shields in cataract surgery | |
| JPH04200472A (en) | Intraocular implanted lens | |
| JPH01115355A (en) | Photoadsorptive composition adaptive to living body |